Clinical trial
A Phase II Efficacy Study of MK-4827 in Patients With Mantle Cell Lymphoma
NCT01244009 is registered in ClinicalTrials.gov with Tesaro, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Efficacy Study of MK-4827 in Patients With Mantle Cell Lymphoma
- Lead sponsor
- Tesaro, Inc.
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- December 31, 2010
- Completion date
- August 31, 2013
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lymphoma, mantle-cell